Medicus Pharma (NASDAQ:MDCX) Issues Earnings Results, Misses Estimates By $0.27 EPS

Medicus Pharma (NASDAQ:MDCX) issued its quarterly earnings data on Friday. The company reported ($0.65) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.27), Zacks reports.

Medicus Pharma Trading Down 2.7%

Medicus Pharma stock opened at $2.20 on Friday. Medicus Pharma has a 52 week low of $1.79 and a 52 week high of $8.94. The stock has a market cap of $39.20 million and a price-to-earnings ratio of -1.02. The company’s 50-day moving average price is $2.41 and its two-hundred day moving average price is $2.98.

Analyst Ratings Changes

Several brokerages have recently issued reports on MDCX. Zacks Research raised shares of Medicus Pharma to a “hold” rating in a report on Monday, September 15th. D. Boral Capital reiterated a “buy” rating and issued a $27.00 price objective on shares of Medicus Pharma in a research report on Thursday. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Medicus Pharma in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.50.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC bought a new stake in Medicus Pharma during the second quarter worth approximately $41,000. Osaic Holdings Inc. increased its position in shares of Medicus Pharma by 180.0% during the 2nd quarter. Osaic Holdings Inc. now owns 14,000 shares of the company’s stock valued at $42,000 after purchasing an additional 9,000 shares during the period. Finally, Private Advisor Group LLC increased its position in shares of Medicus Pharma by 3.8% during the 3rd quarter. Private Advisor Group LLC now owns 151,500 shares of the company’s stock valued at $351,000 after purchasing an additional 5,500 shares during the period.

Medicus Pharma Company Profile

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.